Source: NIH ODS + Miller 2005 meta-analysis
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Vitamin E (Mixed Tocopherols and Tocotrienols) has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
When alpha-tocopherol quenches a lipid peroxyl radical it becomes a tocopheroxyl radical, which is itself mildly oxidising and can propagate chain reactions if it accumulates. Ascorbate sitting in the aqueous phase at the membrane interface donates an electron and regenerates tocopherol. This is textbook antioxidant network chemistry and does not depend on any single trial. It is the reason the two are so often formulated together.
Glutathione peroxidase is a selenoenzyme that reduces lipid hydroperoxides to alcohols. Vitamin E acts earlier, intercepting the peroxyl radical before the hydroperoxide forms. Deficiency of either raises the burden on the other, which is why classic deficiency syndromes in animals responded partially to either nutrient. The pairing is mechanistic and long established, and human outcome data for the combination is a separate question.
The regeneration chain runs tocopherol to ascorbate to glutathione, with each step passing the oxidative burden to a more water-soluble and more easily regenerated species. Glutathione also feeds glutathione peroxidase, which clears the lipid hydroperoxides vitamin E did not intercept. Oral glutathione has its own absorption limits, which is a separate matter from whether the network chemistry holds.
Lipoic acid is reduced in cells to dihydrolipoate, a strong reductant active in both aqueous and lipid environments. That dual solubility lets it feed electrons back into the ascorbate pool that regenerates tocopherol. Most of the direct evidence is from cell and animal systems rather than from human tissue measurement. Read it as mechanistic support for the pairing rather than as a clinical finding.
Reduced coenzyme Q10 is lipid-soluble and sits inside the same membranes as tocopherol, so it can reduce the tocopheroxyl radical in place. That makes it a shorter-range partner than ascorbate, which has to work from the water side. Both routes operate. The pairing is standard in lipid antioxidant formulation.
EPA and DHA carry five and six double bonds respectively, making them far more prone to peroxidation than the fatty acids they displace in membranes. Vitamin E is added to fish oil products for exactly this reason, protecting the oil in the bottle and in tissue. The dietary requirement for vitamin E is conventionally expressed relative to polyunsaturated fat intake. This is nutritional bookkeeping, not a bonus effect.
Alpha-tocopheryl quinone, a tocopherol metabolite, inhibits the vitamin K dependent carboxylation step, and high vitamin E intake has been associated with prolonged clotting measures. The interaction matters most at doses well above what food provides and in anyone already on anticoagulation. It is a genuine reason to keep high-dose vitamin E away from unmanaged anticoagulant use. The effect direction is on clotting time, a laboratory measure.
Retinol and tocopherol are both absorbed via mixed micelles and packaged into chylomicrons, so they compete for the same limited carrier capacity when given together in large amounts. In the other direction, tocopherol slows oxidative degradation of retinoid in oil-based products. Whether the competition matters in practice depends on the dose ratio. Both points are formulation-relevant.
Carotenoids and tocopherols compete for incorporation into mixed micelles and for space in lipoprotein particles. Large single-nutrient doses of either can lower circulating levels of the other. Food-level intakes rarely produce this. The interaction is measured in blood concentrations, which is a marker and not an outcome.
The liver preferentially loads alpha-tocopherol onto nascent VLDL via alpha-tocopherol transfer protein, and tocotrienols bind that protein poorly. Adding a large amount of alpha-tocopherol to a tocotrienol product therefore reduces how much tocotrienol reaches circulation. This is why tocotrienol-focused products keep alpha-tocopherol low. The point is about distribution, not about which molecule is preferable.
Astaxanthin's polar end groups anchor it across the membrane, so it intercepts radicals at a different depth than the tocopherol chromanol head, which sits at the water interface. Covering two positions in the bilayer is a plausible reason to combine them. The membrane-position work is largely from model systems. Human data on the combination is limited.
Tocopherols and tocotrienols require bile salts and dietary fat to form the mixed micelles that carry them across the enterocyte brush border. Taking vitamin E on an empty stomach lowers uptake substantially. Medium chain triglycerides are absorbed differently from long chain fats and enter portal blood directly, so they are a less efficient micelle former than a long chain oil. Any fat-containing meal serves the purpose.
Copper-zinc superoxide dismutase converts superoxide to hydrogen peroxide, reducing the radical flux that would otherwise initiate lipid chain reactions. Vitamin E works further along the same cascade. The two occupy different steps of one defence system, which is why they appear together in antioxidant formulas. Adequate copper matters here too, since the enzyme needs both metals.
Bound copper is essential to superoxide dismutase activity, which limits the radical initiation vitamin E has to mop up. Unbound copper does the opposite, driving Fenton-type chemistry that generates the very radicals tocopherol intercepts. The direction depends entirely on whether the copper is protein-bound. This is why copper is dosed conservatively in antioxidant formulas.
Alpha-tocopherol transfer protein has a strong preference for the alpha form, so supplementing alpha-tocopherol alone lowers plasma gamma-tocopherol. Gamma-tocopherol has distinct chemistry, being better able to quench reactive nitrogen species. A mixed tocopherol product exists precisely to avoid that displacement. Stating this is not a ranking of forms, only a description of what each choice does to the circulating profile.
In an oil-in-water system, tocopherol works in the lipid phase and ascorbate in the aqueous phase, so together they cover both. Ascorbyl palmitate is often used to put ascorbate into the oil side. This is stability chemistry inside the bottle and is separate from any effect after swallowing. The pairing is standard in oil-based supplements.
Nothing specific on file for Vitamin E (Mixed Tocopherols and Tocotrienols). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.